Synthesis and biological activities of ferrocenyl derivatives of paclitaxel

A series of ferrocenyl taxoids were prepared by acylation of paclitaxel and docetaxel with ferrocenecarboxylic acid and 3-ferrocenoylpropionic acid in good yield. The prepared compounds showed high activities against multidrug-resistant colon adenocarcinoma cell lines.

[1]  J. Matta,et al.  Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies. , 2011, Dalton transactions.

[2]  G. Gasser,et al.  Organometallic Anticancer Compounds , 2010, Journal of medicinal chemistry.

[3]  L. Ostrovskaya,et al.  Ferrocene‐modified thiopyrimidines: synthesis, enantiomeric resolution, antitumor activity , 2011 .

[4]  A. Vessières,et al.  Organometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells. , 2010, Dalton transactions.

[5]  A. Vessières,et al.  Comparative toxicity of [3]ferrocenophane and ferrocene moieties on breast cancer cells , 2010 .

[6]  A. Vessières,et al.  Ferrocene Functionalized Endocrine Modulators as Anticancer Agents , 2010 .

[7]  A. Vessières,et al.  A [3]ferrocenophane polyphenol showing a remarkable antiproliferative activity on breast and prostate cancer cell lines. , 2009, Journal of medicinal chemistry.

[8]  J. Xiang,et al.  Synthesis, characterization and in vitro antiproliferative activities of new 13-cis-retinoyl ferrocene derivatives. , 2009, European journal of medicinal chemistry.

[9]  D. Rai,et al.  The synthesis, structural characterization and in vitro anti-cancer activity of novel N-(3-ferrocenyl-2-naphthoyl) dipeptide ethyl esters and novel N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters , 2009 .

[10]  D. Bar-Sagi,et al.  Design, synthesis, and biological evaluation of new-generation taxoids. , 2008, Journal of medicinal chemistry.

[11]  A. Goel,et al.  N-ortho-Ferrocenyl benzoyl dipeptide esters: Synthesis, structural characterization and in vitro anti-cancer activity of N-{ortho-(ferrocenyl)benzoyl}-glycine-l-alanine ethyl ester and N-{ortho-(ferrocenyl)benzoyl}-l-alanine-glycine ethyl ester , 2007 .

[12]  Jan-Martin Heldt,et al.  The Presence of a Ferrocenyl Unit on an Estrogenic Molecule is Not Always Sufficient to Generate in vitro Cytotoxicity , 2006, ChemMedChem.

[13]  A. Vessières,et al.  A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents , 2006, ChemMedChem.

[14]  J. Veith,et al.  Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents. , 2006, Bioorganic & medicinal chemistry letters.

[15]  V. N. Babin,et al.  Synthesis, structure and redox potentials of biologically active ferrocenylalkyl azoles , 2004 .

[16]  K. Lee,et al.  Antitumor agents 216. Synthesis and evaluation of paclitaxel-camptothecin conjugates as novel cytotoxic agents. , 2003, Bioorganic & medicinal chemistry.

[17]  P. Low,et al.  Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics. , 2002, Bioorganic & medicinal chemistry.

[18]  S. Baker,et al.  Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  I. Ojima,et al.  Efficient Asymmetric Syntheses of β-Lactams Bearing a Cyclopropane or an Epoxide Moiety and Their Application to the Syntheses of Novel Isoserines and Taxoids , 1998 .

[20]  C. Biot,et al.  Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. , 1997, Journal of medicinal chemistry.

[21]  G. Jaouen,et al.  FACILE ROUTE TO FERROCIFEN, 1-4-(2-DIMETHYLAMINOETHOXY)-1-(PHENYL-2-FERROCENYL-BUT-1-ENE), FIRST ORGANOMETALLIC ANALOGUE OF TAMOXIFEN, BY THE MCMURRY REACTION , 1997 .

[22]  P. Vrignaud,et al.  Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. , 1996, Journal of medicinal chemistry.

[23]  A. Vessières,et al.  Ferrocenyl hydroxytamoxifen: a prototype for a new range of oestradiol receptor site-directed cytotoxics , 1996 .

[24]  V. N. Babin,et al.  Antitumor effects of binuclear ferrocene derivatives , 1993 .

[25]  J. Besancon,et al.  Synthèe, caractérisation et propriétés cytotoxiques des premiers ‘métallocénonucléosides’ , 1991 .

[26]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.